Radio-guided surgery for persistent differentiated papillary thyroid cancer:: case presentations and review of the literature

被引:23
作者
Negele, T. [1 ]
Meisetschlaeger, G. [1 ]
Brueckner, T. [1 ]
Scheidhauer, K. [1 ]
Schwaiger, M. [1 ]
Vogelsang, H. [1 ]
机构
[1] Univ Polytech, Dept Surg, Interdisciplinary Ctr Thyroid Dis, Klinikum Rechts Isar, D-81675 Munich, Germany
关键词
thyroid cancer; surgery; radio-guided; radioiodine;
D O I
10.1007/s00423-005-0013-5
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background and aims: Persistent differentiated papillary thyroid cancer following radical locoregional surgery with metastases is an indication for limited reoperation or radioiodine therapy. Following injection of radioiodine, radio-guided surgery with application of an intraoperative gamma probe offers detection of metastases not seen by conventional imaging and control of completeness of resection. Patients/methods: We demonstrate four patients with locoregional metastases, two of them with additional distant metastases of papillary thyroid cancer following radical neck surgery. Postoperative radioiodine scans demonstrated persistent ipsilateral or contralateral cervical and mediastinal lymph node and isolated rib metastases. Results: Radio-guided surgery (RGS) leads to complete clearance of persistent lymph node metastases by limited recurrent neck surgery, resection of metastases not seen by conventional imaging and control of complete mediastinal lymph node dissection. Post-RGS scans allowed early diagnosis of occult diffuse or nodal pulmonary metastases in two patients. At last follow-up, 23 to 48 months following RGS and radioiodine therapy, there was no evidence of disease. Conclusions: Radio-guided surgery is an additive surgical technique with low morbidity in selected patients with persistent thyroid cancer individualizing tumor therapy options in multimode oncological therapy.
引用
收藏
页码:178 / 186
页数:9
相关论文
共 25 条
  • [1] CASARA D, 1993, J NUCL MED, V34, P1626
  • [2] CECCARELLI C, 1988, SURGERY, V104, P1143
  • [3] Follicular thyroid carcinoma - Prognostic factors and the role of radioiodine
    Chow, SM
    Law, SCK
    Mendenhall, WM
    Au, SK
    Yau, S
    Yuen, KT
    Law, CC
    Lau, WH
    [J]. CANCER, 2002, 95 (03) : 488 - 498
  • [4] RECURRENT THYROID-CANCER ROLE OF SURGERY VERSUS RADIOACTIVE IODINE (I-131)
    COBURN, M
    TEATES, D
    WANEBO, HJ
    [J]. ANNALS OF SURGERY, 1994, 219 (06) : 587 - 595
  • [5] PROGNOSTIC FACTORS AND MANAGEMENT CONSIDERATIONS IN PATIENTS WITH CERVICAL METASTASES OF THYROID-CANCER
    COBURN, MC
    WANEBO, HJ
    [J]. AMERICAN JOURNAL OF SURGERY, 1992, 164 (06) : 671 - 676
  • [6] RADIOIODINE IN TREATMENT OF METASTATIC THYROID-CANCER
    DEWAN, SS
    SHARMA, SM
    GANATRA, RD
    [J]. INTERNATIONAL JOURNAL OF NUCLEAR MEDICINE & BIOLOGY, 1979, 6 (04): : 213 - 214
  • [7] *DTSCH KREBSG DTSC, 2002, MAL SCHILDDR INT LEI
  • [8] Gamma probe-guided resection of a lymph node metastasis with I-123 in papillary thyroid carcinoma
    Gallowitsch, HJ
    Fellinger, J
    Mikosch, P
    Kresnik, E
    Lind, P
    [J]. CLINICAL NUCLEAR MEDICINE, 1997, 22 (09) : 591 - 592
  • [9] SURGICAL REINTERVENTION FOR DIFFERENTIATED THYROID-CANCER
    GORETZKI, PE
    SIMON, D
    FRILLING, A
    WITTE, J
    REINERS, C
    GRUSSENDORF, M
    HORSTER, FA
    ROHER, HD
    [J]. BRITISH JOURNAL OF SURGERY, 1993, 80 (08) : 1009 - 1012
  • [10] Use of surgical gamma probe for the detection of lymph node metastases in differentiated thyroid cancer
    Lippi, F
    Capezzone, M
    Miccoli, P
    Traino, C
    Di Martino, F
    Angelini, F
    Spinelli, C
    Iacconi, P
    Pinchera, A
    Pacini, F
    [J]. TUMORI, 2000, 86 (04) : 367 - 369